Condition

Contraception

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 60 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials60

Recruiting4

Common interventions25

Lead sponsors shown15

Clinical trials

60 shown

Pharmacokinetic Study of Long-acting Antiretrovirals and Contraceptives in HIVNCT07516548 · 2025-01-24

Pharmacokinetics of Drospirenone Only Pills: A Pre- and Post-Bariatric Surgery StudyNCT06345560 · 2024-04-18

Drospirenone Only Pills and Cervical Mucus Changes: A Pre- and Post-Bariatric Surgery StudyNCT06345586 · 2024-04-18

Kuwa Free! - Live Free!NCT05044962 · 2021-11-26

DYnamic decisioN Support for IntegrAting PrEP in Clinics for Young People in Alabama and BotswanaNCT07597824 · 2026-10-01

NOT_YET_RECRUITING

Exploring Reproductive Health Among Women in SomalilandNCT07438379 · 2025-01-01

ENROLLING_BY_INVITATION

A Crossover Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy PreventionNCT04778514 · 2022-12-07

Mobile Phone Messaging to Improve Reproductive Health for Women Living With HIV in Kenya (Mobile WACh Empower)NCT05285670 · 2022-12-01

ACTIVE_NOT_RECRUITING

Supporting Young Women's Reproductive Health by Harnessing Prosociality Among Drug ShopkeepersNCT05525533 · 2022-07-01

Evaluation of Pharmacokinetic Drug-drug Interactions Between Hormonal Contraceptives and Doravirine-containing ART Among Women Living With HIV in South AfricaNCT04669678 · 2021-11-17

Investigating the Interaction Between Two Long-acting Reversible Methods of Contraception and Dolutegravir, a Treatment for HIVNCT04910711 · 2021-10-21

Intervening on Women's Health for Rural Young Breast Cancer SurvivorsNCT05414812 · 2021-10-15

PrEParing Family Planning Clinics to Streamline Integration of HIV Prevention Services for Young Women in KenyaNCT04666792 · 2021-03-01

Contraception and Pregnancy in Diabetes MellitusNCT04523454 · 2020-10-02

Breast Cancer and Intrauterine ContraceptionNCT05148910 · 2020-08-06

Sexual and Reproductive Health (Including PrEP and HBV) for Female Sex Workers in Côte d'IvoireNCT03985085 · 2019-11-26

Reaching Adolescent Girls and Young Women Through Girl-Friendly Drug VendorsNCT04045912 · 2019-07-22

Pharmacologic Strategies for the Etonogestrel Implant in HIV-Infected WomenNCT03282799 · 2019-02-19

Tenofovir/Levonorgestrel Intravaginal Ring and Tenofovir Intravaginal RingNCT03762382 · 2018-12-12

Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive ImplantNCT03589040 · 2018-09-25

Counseling on Injectable Contraception and HIV Risk in TanzaniaNCT04160169 · 2018-09-01

Darunavir and Rilpivirine Interactions With Levonorgestrel ImplantNCT03589027 · 2018-08-07

PK Study of 90-Day Use of Vaginal Rings Containing Dapivirine and LevonorgestrelNCT03467347 · 2018-07-17

Pharmacokinetics and Pharmacodynamics of DMPA With HIV PrEPNCT03197961 · 2017-11-17

Modifiers of Tenofovir in the Female Genital TractNCT03377608 · 2017-11-17

Contraceptive/HIV Affecting Risk in AdolescentsNCT03301480 · 2017-07-31

Effectiveness of Orally Dosed Emergency Contraception in Obese Women - UPANCT02859337 · 2017-05-30

Pharmacologic Strategies to Use the Levonorgestrel Implant in HIV-infected WomenNCT02722421 · 2017-04-06

Compare Daily Ulipristal Acetate and Combined Oral Contraceptive Effects on Breast Epithelial Cell ProliferationNCT02922127 · 2016-12-16

High-risk Obstetrical Patient Intervention Utilizing the Contraceptive CHOICE Project ScriptNCT03049592 · 2016-07-01

The Quatro Study: Acceptability Study of (Placebo) Vaginal Delivery Forms for Preventing HIV and Unintended PregnancyNCT02602366 · 2016-06-06

The Evidence for Contraceptive Options and HIV Outcomes TrialNCT02550067 · 2015-12-14

Protease Inhibitors and Combined Oral Contraceptive Pharmacokinetics and PharmacodynamicsNCT02531321 · 2015-08-01

EC PK in Women With Normal and Obese BMINCT02689804 · 2015-07-10

Reproductive Health Survivorship Care PlanNCT02667626 · 2015-03-25

Impact of Hormonal Contraception on HIV Acquisition and Transmission RiskNCT02357368 · 2015-02-01

Emergency Contraception and Body Weight: Pilot StudyNCT02408692 · 2015-02-01

A Pharmacokinetic Evaluation of Etonogestrel (ENG) Implant and Antiretroviral TherapyNCT02082652 · 2014-10-01

Phase I One-month Safety, PK, PD, and Acceptability Study of IVR Releasing TFV and LNG or TFV AloneNCT02235662 · 2014-10-01

Clinical Trial on the Effects of Progestin-based Contraception in the Genital Tract of HIV-infected and Uninfected WomenNCT02103660 · 2014-04-08

A Pharmacokinetic Evaluation of Levonorgestrel Implant and Antiretroviral TherapyNCT01789879 · 2014-03-04

The Effect of Early Versus Traditional Follow-Up on Breastfeeding Rates at 6 MonthsNCT02221895 · 2014-03-01

HIV-Target Cell Response in Women Initiating Various Contraceptive Methods in High HIV-Incidence Areas: Zim CHICNCT02038335 · 2014-02-01

Quantification of Immune Cells in Women Using Contraception (CHIC II)NCT01873170 · 2013-08-01

Obesity and Oral Contraceptive FailureNCT01944306 · 2013-08-01

Evaluation of a Peer Education Program to Promote Family Planning Among Female Sex Workers in KenyaNCT01957813 · 2013-06-20

Family Planning Knowledge, Attitudes, and Practices of Postpartum Malawian WomenNCT01893021 · 2013-05-01

The Effect of Body Mass Index on Etonogestrel Hormone Levels in Women Using the Single-rod Contraceptive ImplantNCT01855620 · 2012-12-01

Mobile Phone Text Messaging ReferralNCT01746758 · 2012-08-01

Choices-Teen: A Bundled Risk Reduction Intervention for Juvenile Justice FemalesNCT02252471 · 2012-07-01

Acceptability of Depo-subQ in UnijectNCT01667276 · 2012-07-01

A Prospective Observational Study of the Clinical Performance of Femplant in PakistanNCT01463254 · 2011-10-01

Enhancing Uptake of Family Planning Services by HIV-Infected Women Attending the PMTCT ProgramNCT03019601 · 2011-09-01

Safety,Effectiveness and Acceptability of Sino-implant II in DRNCT01594632 · 2011-01-01

US Ovulation Inhibition Study in Obese WomenNCT00873483 · 2009-04-30

Impact of Different Contraceptives on the Immune System of HIV Infected Women in ZambiaNCT00807625 · 2008-11-01

Pharmacokinetics of Implanon in Obese WomenNCT00724438 · 2008-07-01

Assessing Preference for 3 Female Condoms: A Comparative Evaluation of the PATH Woman's Condom, FC2 and the Reddy 6NCT01452503 · 2007-05-01

A Study of the Drug Interactions Between a Hormonal Emergency Contraception and an HIV MedicationNCT00482963 · 2007-05-01

Oral Contraceptive Efficacy and Body WeightNCT00662454 · 2006-01-01

Common interventions

Leading sponsors

FHI 360 6 University of Alabama at Birmingham 5 Oregon Health and Science University 4 University of Pittsburgh 4 Columbia University 3 CONRAD 3 University of California, San Diego 3 Chulalongkorn University 2 Makerere University 2 University of California, San Francisco 2 University of Nebraska 2 University of North Carolina, Chapel Hill 2 University of Washington 2 ANRS, Emerging Infectious Diseases 1 Bayer 1

Trial status mix

COMPLETED42

UNKNOWN7

RECRUITING4

TERMINATED4

ACTIVE_NOT_RECRUITING1

ENROLLING_BY_INVITATION1

NOT_YET_RECRUITING1

Phase mix

NA20

PHASE411

PHASE29

PHASE15

EARLY_PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.